Market Research Reports

Categories

Countries

Pharmaceuticals Reports

India Cephalexin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Liquid suspension, Injection, Others), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Respiratory Tract Infections, Otitis Media, Skin and Skin Structure Infections, Bone Infections, Genitourinary Infections, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India cephalexin market.Read More

India Clarithromycin Market By Application (Strep throat, Pneumonia, Skin Infections, Respiratory Infections, Lyme Disease, Helicobacter Pylori Infection, Others), By Form (Tablet, Capsule, Suspension, Others), By Route of Administration (Oral vs Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing occurrence of bacterial infections is expected to drive the growth of India clarithromycin market during the forecast period.Read More

India Ceftriaxone Market By Dose (100 mg, 200 mg, 250 mg, 500 mg and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Intramuscular Injection, Intravenous Injection, Infusion, Others), By Distribution Channel (Online v/s Offline), By Application (Endocarditis, Meningitis, Pneumonia, Bone and Joint Infections, Intra-Abdominal Infections, Skin Infections, Urinary Tract Infections, Gonorrhoea, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India ceftriaxone market during the forecast period.Read More

India Tetracycline Market By Product Type (OTC v/s Prescription), By Type (Tetracycline Hydrochloride v/s Tetracycline Phosphate), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Powder, Ointments, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Respiratory, Bowel, Genital, Systemic Infections, Others), By Route of Administration (Oral, Topical, Ophthalmic), By Company, By Region, Forecast & Opportunities, FY2026

Growing adoption of tetracycline for infectious treatment is expected to drive the growth of India tetracycline market during the forecast period.Read More

India Cefoperazone Market By Composition (Single, Combinational), By Route of Administration (Intramuscular v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Respiratory Infections, Skin Infections, Urinary Infections, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India cefoperazone market during the forecast period.Read More

India Losartan Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (25 mg, 50 mg, 100 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of hypertension is expected to drive the growth of India Losartan market during the forecast period.Read More

India Gabapentin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing epilepsy and restless legs syndrome is expected to drive the growth of India Gabapentin market during the forecast period.Read More

India Gentamycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Eye Drops, Tablet, Capsule, Syrup, Injection, Cream, Gel, Ointment, Others), By Route of Administration (Ophthalmic, Intravenous, Topical, Oral, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infection, Urinary Tract Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory Tract Infection, Others), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India gentamycin market.Read More

India Doxycycline Market By Product Type (Doxycycline HCL, Doxycycline Hyclate, Doxycycline Calcium, Doxycycline Monohydrate), By Form (Tablet, Capsule, Injection, Solution, Syrup, Others), By Application (Intestinal Infections, Respiratory Tract Infections, Skin Infections, Genital Infections, Urinary Tract Infections, Others), By Route of Administration (Oral, Intravenous, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India doxycycline market.Read More

India Ornidazole Market By Composition (Single, Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Injection, Capsule, Others), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Vaginal Infections, Urinary Tract Infections, Intestinal Infections, Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of infections is expected to drive the growth of India ornidazole market.Read More

Global Nasal Drug Delivery Market By Type of Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplant, Others), By Cell Type (B-cell Lymphomas, T-cell Lymphoma), By Drug Type (Opdivo, Adcetris, Rituxan, Imbruvica, Revlimid, Keytruda, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Forecast & Opportunities, 2025

Increasing prevalence of various respiratory disorders and demand for non-invasive techniques to drive global nasal drug delivery marketRead More

India Olmesartan Market By Dose (10 mg, 20 mg, 40 mg, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (High Blood Pressure, Heart Failure, Diabetic Kidney Disease Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of hypertension is expected to drive the growth of India Olmesartan market during the forecast period.Read More

India Telmisartan Market By Indication (Hypertension, Cardiac Arrest, Stroke, Others), By Composition (Single, Combinational), By Form (Tablet, Capsule, Injection, Others), By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of hypertension is expected to drive the growth of India Telmisartan market during the forecast period.Read More

India Clindamycin HCL Market By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Skin and Soft Tissue Infections, Respiratory Tract Infections, Lung Infections, Others), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India clindamycin HCL market.Read More

India Tinidazole Market By Industry (Chemical Industry v/s Pharmaceutical Industry), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Injection, Capsule, Syrup, Others), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Amoebiasis, Amoebic liver Abscess, Bacterial vaginosis, Giardiasis, Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India tinidazole market.Read More

India Ciprofloxacin Market By Composition (Single v/s Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic, Intravenous, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin structure Infections, Bone and Joint infections, Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India ciprofloxacin market.Read More

India Valsartan Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Heart Failure, Myocardial Infarction, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of cardiovascular diseases is expected to drive the growth of India valsartan market.Read More

India Sulfadiazine Market By Product Type (OTC v/s Prescription), By Route of Administration (Oral, Topical, Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Cream, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Ear Infections, Meningitis, Malaria, Toxoplasmosis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of microbial infections is expected to drive the growth of India sulfadiazine market.Read More

India Atorvastatin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Capsule), By Distribution Channel (Online v/s Offline), By Application (Hypercholesterolemia, By Hypertriglyceridemia, Dyslipidaemia, Others), By Company, By Region, Forecast & Opportunities, FY2026

High prevalence of cardiovascular diseases is expected to drive the growth of India atorvastatin market.Read More

India Acyclovir Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Ointment/Cream, Injection, Powder for Solution, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Type of Virus (Herpes Simplex Virus Type I (HSV-1), Herpes Simplex Virus Type II (HSV-2), Varicella Zoster Virus (VZV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV)), By Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others), By Distribution Channel (Online v/s Offline), By Application (Cold Soares, Chickenpox, Genital Herpes, Shingles, Hepatitis, HIV, Influenza, Others), By End User (Children up to 12 years v/s Adults), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of viral diseases is expected to drive the growth of India acyclovir market.Read More


   Page 1 of 3 Next